A New Procedure for Testing Equivalence in Comparative Bioavailability and Other Clinical Trials

Communications in Statistics - Theory and Methods

Volumn 12, Issue 23, 1983, Pages 2663-2692

  Sharon, Anderson ^a   Hauck, Walter W ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

bioequivalence; clinical trials; completely randomized design; composite null hypothesis; crossover design; noncentral t distribution

Indexed keywords

EID: 84947888949     PISSN: 03610926     EISSN: 1532415X     Source Type: Journal    
DOI: 10.1080/03610928308828634     Document Type: Article

References (20)

1. Anderson, S. and Hauck, W.W. (1981). Testing Equivalence in Comparative Bioavailability Trials. Presented at August, 1981 Joint Statistical Meetings in Detroit, Michigan.
2. Beckhofer, R.E., Dunnett, C.W., and Sobel, M. (1954). A Two-Sample Multiple Decision Procedure for Ranking Means of Normal Populations With a Common Unknown Variance. Biometrika 41, 170–176.
3. Cooper, B.E. (1968). The Integral of the Non-central t Distribution (Algorithm AS 5). Applied Statistics 17, 193–194.
4. Dantzig, G.B. (1940). On the Non-Existence of Tests of Student’s Hypothesis Having Power Functions Independent of σ. Annals of Mathematical Statistics 11, 186–192.
5. Dunnett, C.W. and Gent, M. (1977). Significance Testing to Establish Equivalence Between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables. Biometrics 33, 593–602.
6. Food and Drug Administration (1977). The Bioavailability Protocol Guideline for ANDA and NDA Submission. Division of Biopharmaceutics, Drug Monographs/Bureau of Drugs, Food and Drug Administration.
7. Hill, I.D. (1978). A Remark on Algorithm AS 76: An Integral Useful in Calculating Non-central t and Bivariate Normal Probabilities. Applied Statistics 27, 379.
8. Kirkwood, T.B.L. (1981). Bioequivalence Testing - A Need to Rethink. Biometrics 37, 589-591.
9. Langenberg, P. and Srinivasan, R. (1980). An Indifference Zone Approach to Bioequivalence. Presented at August, 1980 Joint Statistical Meetings in Houston, Texas.
10. Learmonth, G.P., and Lewis, P.A.W. (1973). Random Number Generator Package LLRANDOM. Monterey, Calif.: Naval Postgraduate School, Report #NPS55LW73061A.
11. Lewis, P.A.W., Goodman, A.S., and Miller, J.M. (1969). Pseudo-Random Number Generator for the System/360. IBM Systems Journal, No. 2, 136–146.
12. Mandallaz, D. and Mau, J. (1981). Comparison of Different Methods for Decision-Making in Bioequivalence Assessment. Biometrics 37, 213–222.
13. Metzler, C.M. (1974). Bioavailability - A Problem in Equivalence. Biometrics 30, 309–317.
14. Schuirmann, D.J. (1982). Fixed Sample Tests for Interval Hypotheses Associated with Bioequivalence Trials. Presented at August, 1982 Joint Statistical Meetings in Cincinnati, Ohio.
15. Selwyn, M.R., Dempster, A.P., and Hall, N.R. (1981). A Bayesian Approach to Bioequivalence for the 2x2 Changeover Design. Biometrics 37, 11–21.
16. Westlake, W.J. (1972). Use of Confidence Intervals in Analysis of Comparative Bioavailability Trials. Journal of Pharmaceutical Sciences 61, 1340–1341.
17. Westlake, W.J. (1976). Symmetric Confidence Intervals for Bioequivalence Trials. Biometrics 32, 741–744.
18. Westlake, W.J. (1979). Design and Statistical Evaluation of Bioequivalence Studies in Man. Principles and Perspective in Drug Bioavailability, Karger, Basel, 192-210.
19. Westlake, W.J. (1981). Response to Bioequivalence Testing - A Need to Rethink. Biometrics 37, 591–593.
20. Young, J.C., and Minder, C.E. (1974). An Integral Useful in Calculating Non-central t and Bivariate Normal Probabilities (Algorithm AS 76). Applied Statistics 23, 455–457.